Physician profile
Meredith Moore
NPI 1639777972
$366.41
in general payments reported to CMS, 2019-2025
12 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.27 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.14 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $125.29 | 2025 | Veozah |
| Abiomed | $33.97 | 2025 | |
| Braeburn INC. | $24.52 | 2025 | Brixadi |
| Gilead Sciences, INC. | $24.39 | 2025 | |
| Exact Sciences Corporation | $23.74 | 2025 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $23.71 | 2025 | Voquezna |
| Supernus Pharmaceuticals, INC. | $21.77 | 2025 | Qelbree |
| Organon LLC | $19.33 | 2021 | |
| Merck Sharp & Dohme LLC | $19.21 | 2025 | Enflonsia, Capvaxive, Rotateq |
| Therapeuticsmd, INC. | $17.94 | 2021 | |
| Lilly USA, LLC | $16.61 | 2025 | Mounjaro |
| Abbvie INC. | $15.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.